JCU > Research Portfolio > Dr Erik Biros

About

Research Disciplines: Cardiovascular Medicine and Haematology (1102)

Clinical Sciences (1103)
Socio-Economic Objectives: Clinical Health (9201)

Health and Support Services (9202)

Publications

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

Langdon K, Phie J, Thapa C, Biros E, Loukas A and Haleagrahara N (2019) Helminth-based therapies for rheumatoid arthritis: a systematic review and meta-analysis. International Immunopharmacology, 66. pp. 366-372
Letson H, Morris J, Biros E and Dobson G (in press) ALM fluid therapy leads to 72 hr survival after hemorrhagic shock. Journal of Trauma and Acute Care Surgery,
Dewdney B, Trollope A, Moxon J, Thomas Manapurathe D, Biros E and Golledge J (2018) Circulating microRNAs as biomarkers for acute ischemic stroke: a systematic review Journal of Stroke and Cerebrovascular Diseases. Journal of stroke and cerebrovascular diseases, 27 (3). pp. 522-530
Li J, Huynh P, Dai A, Wu T, Tu Y, Chow B, Kiriazis H, Du X, Bach L, Wilkinson-Berka J, Biros E, Walker P, Nataatmadja M, West M, Golledge J, Allen T, Cooper M and Chai Z (2018) Diabetes reduces severity of aortic aneurysms depending on the presence of cell division autoantigen 1 (CDA1). Diabetes, 67 (4). pp. 755-768
Biros E, Moran C, Maguire J, Holliday E, Levi C and Golledge J (2017) Upregulation of arylsulfatase B in carotid atherosclerosis is associated with symptoms of cerebral embolization. Scientific Reports, 7 (1).
Iyer V, Rowbotham S, Biros E, Bingley J and Golledge J (2017) A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms. Atherosclerosis, 261. pp. 78-89
Krishna S, Seto S, Jose R, Li J, Morton S, Biros E, Wang Y, Nsengiyumva V, Lindeman J, Loots G, Rush C, Craig J and Golledge J (2017) Wnt signaling pathway inhibitor sclerostin inhibits angiotensin II-induced aortic aneurysm and atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology, 37 (3). pp. 553-566
Moran C, Biros E, Krishna S, Wang Y, Tikellis C, Moxon J, Cooper M, Norman P, Burrell L, Thomas M and Golledge J (2017) Resveratrol inhibits growth of experimental abdominal aortic aneurysm associated with upregulation of angiotensin-converting enzyme 2. Arteriosclerosis Thrombosis and Vascular Biology, 37 (11). pp. 2195-2218
Moran C, Seto S, Krishna S, Sharma S, Jose R, Biros E, Wang Y, Morton S and Golledge J (2017) Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis. Scientific Reports, 7. pp. 1-12
Reznik J, Biros E, Sacher Y, Kibrik O, Milanese S, Gordon S and Galea M (2017) A preliminary investigation on the effect of extracorporeal shock wave therapy as a treatment for neurogenic heterotopic ossification following traumatic brain injury. Part II: effects on function. Brain Injury, 31 (4). pp. 533-541
Reznik J, Biros E, Lamont A, Sacher Y, Kibrik O, Milanese S, Gordon S and Galea M (2017) A preliminary investigation on the effect of extracorporeal shock wave therapy as a treatment for neurogenic heterotopic ossification following traumatic brain injury. Part I: effects on pain. Brain Injury, 31 (4). pp. 526-532
Thomas Manapurathe D, Krishna S, Dewdney B, Moxon J, Biros E and Golledge J (2017) Effect of blood pressure lowering medication on peripheral artery disease: a meta-analysis of randomised controlled trials. PLoS ONE, 12 (6). pp. 1-12

More: ResearchOnline@JCU stores 51+ research outputs authored by Dr Erik Biros from 2005 onwards.

Current Funding

Current and recent Research Funding to JCU is shown by funding source and project.

Department of Health - Pharmacy Trial Program

Integrated Practice Pharmacists within Aboriginal Community Controlled Health Services

Indicative Funding: $1,040,046 over 3 years (administered by Pharmaceutical Society of Australia)
Summary: Aboriginal and Torres Strait Islander peoples experience a much higher burden of disease due to heart disease, diabetes and other chronic health problems. Many deaths from these illnesses can be prevented if patients are better supported to take their medicines and prescribing quality is improved. This trial will explore if including a practice pharmacist in the primary health care team within Aboriginal community controlled health services (ACCHSs) leads to improvements in the quality of care that Aboriginal and Torres Strait Islander people receive. Our trial will tell us if prescribing by doctors is improved, if patients are more likely to take their medicines, and if indicators of their health are improving over time.
Investigators: Sophie Couzos, Rhondda Jones, Emily Callander, Erik Biros, Deb Smith, Michelle Bellingan, Beverley Glass, Priscilla Page, Donald Whaleboat, Robyn Preston, Nicole Bates, Douglas Boyle, Vicki Slinko, Roderick Wright, Nadia Lusis, Elizabeth Moore and Kathryn Panaretto (College of Medicine & Dentistry, Division of Tropical Health & Medicine, College of Public Health, Medical & Vet Sciences, The University of Melbourne, Queensland Aboriginal & Islander Health Council, Victorian Aboriginal Community Controlled Health Organisation, Aboriginal Medical Services Alliance Northern Territory and Gidgee Healing Mount Isa Aboriginal Community Controlled Health Services Ltd)
Keywords: Aboriginal Health; integrated health care; continuing quality improvement; Primary Health Care; practice pharmacist; community based participatory research

Supervision

Advisory Accreditation: I can be on your Advisory Panel as a Primary or Secondary Advisor.

These Higher Degree Research projects are either current or by students who have completed their studies within the past 5 years at JCU. Linked titles show theses available within ResearchOnline@JCU.

Current

CPR Induced Consciousness - The Management and Treatment of the Interfering Patient (PhD , Primary Advisor)

Completed

Neurogenic heterotopic ossification: prevalence, risk factors, management and treatment (2016, PhD , Associate Advisor)

Collaboration

The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.